PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cancer Biology Laboratory, Department of Biochemistry, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.\', \'School of Biosciences and Technology, VIT University, Vellore, Tamil Nadu, India.\', \'Laboratory of Stem Cells and Neuroregeneration, Department of Animal Science, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India; Faculty Recharge Programme, University Grants Commission (UGC-FRP), New Delhi, India.\', \'Department of Biochemistry, ICMR-National Institute for Research in Environmental Health, Bhauri, Madhya Pradesh, India.\', \'Cancer Biology Laboratory, Department of Biochemistry, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. Electronic address: ravikumarbdu@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0024-3205(20)31636-210.1016/j.lfs.2020.118883
?:hasPublicationType
?:journal
  • Life sciences
is ?:pmid of
?:pmid
?:pmid
  • 33316266
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.071
?:rankingScore_hIndex
  • 145
is ?:relation_isRelatedTo_publication of
?:title
  • Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-β signalling in COVID-19 survivors.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all